Cyclooxygenase-2 expression is associated with VEGF-C and lymph node metastases in gastric cancer patients.
暂无分享,去创建一个
[1] P. Kyzas,et al. COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma , 2005, Modern Pathology.
[2] B. Aggarwal,et al. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. , 2004, Cancer research.
[3] Bingya Liu,et al. Vascular Endothelial Growth Factor C Expression in Gastric Carcinoma and Its Relationship with Lymph Node Metastasis , 2004 .
[4] M. Osaki,et al. Cyclooxygenase-2 expression in human gastric tubular adenomas and carcinomas; correlation with intratumoral microvessel density and apoptotic index. , 2004, Anticancer research.
[5] M. McCarter,et al. Lymphangiogenesis is pivotal to the trials of a successful cancer metastasis. , 2004, Surgery.
[6] J. Shih,et al. Cyclooxygenase-2 Induces EP1- and HER-2/Neu-Dependent Vascular Endothelial Growth Factor-C Up-Regulation , 2004, Cancer Research.
[7] T. Saito,et al. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis , 2004, Scandinavian journal of gastroenterology.
[8] K. Wester,et al. HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer. , 2004, Acta oncologica.
[9] K. Komiyama,et al. Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody , 2004, Virchows Archiv.
[10] K. Hatakeyama,et al. Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis. , 2003, Clinical breast cancer.
[11] C. Buskens,et al. Cyclooxygenase‐2 and gastric carcinogenesis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[12] W. Jiang,et al. Quantitative analysis of lymphangiogenic markers in human colorectal cancer. , 2003, International journal of oncology.
[13] S. Nathanson,et al. Insights into the mechanisms of lymph node metastasis , 2003, Cancer.
[14] Zenta Walther. COX-2 and angiogenesis in gastric cancer. , 2003, Journal of clinical gastroenterology.
[15] A. Saaristo,et al. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck , 2003, Head & neck.
[16] S. Stacker,et al. The role of tumor lymphangiogenesis in metastatic spread , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] J. Reis-Filho,et al. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. , 2002, Journal of clinical pathology.
[18] M. Detmar,et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype , 2002, The EMBO journal.
[19] Li Zhu,et al. Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44* , 2001, The Journal of Biological Chemistry.
[20] D. Jackson,et al. LYVE-1, the lymphatic system and tumor lymphangiogenesis. , 2001, Trends in immunology.
[21] M. Korc,et al. Overexpression of Lymphangiogenic Growth Factor VEGF-C in Human Pancreatic Cancer , 2001, Pancreas.